• A Massachusetts ballot question that would allow adults to grow, use, and possess many psychedelic substances appears poised for defeat.
• With 80% of precincts reporting, opponents of the measure are leading 56.7% to 43.3%.
• The substances that would be legalized under the proposal are psilocybin and psilocin, which are found in "magic mushrooms," as well as dimethyltryptamine, mescaline, and ibogaine.
• Oregon and Colorado already allow the use of some psychedelic substances.
• Psychedelic drug developers: Mind Medicine (NASDAQ:MNMD), Compass Pathways (NASDAQ:CMPS), Cybin (NYSE:CYBN), Atai Life Sciences (NASDAQ:ATAI), Enveric Bio (ENVB), Revive Therapeutics (OTCQB:RVVTF), Bright Minds Biosciences (DRUG), GH Research (GHRS), Clearmind Medicine (CMND).

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。